The Nordic AML Group’s Educational Working Group invites you to a scientific webinar focusing on recent innovations in the treatment of AML and their implementation in Nordic clinical practice. The webinar will feature three expert speakers covering: - The evolving AML treatment landscape by professor Gail Roboz (New York) - Early Nordic experience with new […]
Otsuka, in collaboration with the Center for Myeloid Blood Cancer (CMYC) in Bergen, arranges an AML webinar with the purpose to increase the knowledge of current less intensive AML therapies. Read more and register here: AML webinar with A Isidori Agenda x Welcome and product information, by Ivar Haukeland, BM, Otsuka Pharma Scandinavia AB x […]
Agenda and meeting link will be sent via e-mail.
Take the chance to join an Astellas Pharma sponsored webinar with Dr. Mark J. Levis, MD, PhD, Baltimore, USA, entitled Ask the expert: FLT3 MRD testing in AML patients via Teams with the following agenda: Assess the current minimal residual disease testing modalities/methods Evaluate appropriate timing and efficacy of different FLT3 MRD testing modalities […]